Ironwood Investment Management’s Seres Therapeutics MCRB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-1,825
| Closed | -$25.5K | – | 169 |
|
|
2025
Q1 | $25.5K | Sell |
1,825
-154
| -8% | -$2.41K | 0.01% | 162 |
|
|
2024
Q4 | $32.9K | Sell |
1,979
-302
| -13% | -$4.91K | 0.02% | 167 |
|
|
2024
Q3 | $43.2K | Buy |
2,281
+116
| +5% | +$2.35K | 0.02% | 170 |
|
|
2024
Q2 | $31.3K | Sell |
2,165
-100
| -4% | -$1.67K | 0.02% | 166 |
|
|
2024
Q1 | $35.1K | Buy |
2,265
+235
| +12% | +$5.07K | 0.02% | 171 |
|
|
2023
Q4 | $56.8K | Sell |
2,030
-241
| -11% | -$6.33K | 0.03% | 162 |
|
|
2023
Q3 | $108K | Sell |
2,271
-77
| -3% | -$5.88K | 0.07% | 154 |
|
|
2023
Q2 | $225K | Sell |
2,348
-42
| -2% | -$4.57K | 0.13% | 143 |
|
|
2023
Q1 | $271K | Buy |
2,390
+1,598
| +202% | +$173K | 0.17% | 127 |
|
|
2022
Q4 | $88.7K | Sell |
792
-22
| -3% | -$2.95K | 0.06% | 158 |
|
|
2022
Q3 | $105K | Buy |
814
+2
| +0.2% | +$205 | 0.07% | 157 |
|
|
2022
Q2 | $56K | Buy |
812
+1
| +0.1% | +$86 | 0.04% | 164 |
|
|
2022
Q1 | $115K | Buy |
811
+11
| +1% | +$1.69K | 0.06% | 169 |
|
|
2021
Q4 | $133K | Buy |
800
+19
| +2% | +$3.02K | 0.07% | 176 |
|
|
2021
Q3 | $109K | Buy |
781
+1
| +0.1% | +$196 | 0.06% | 171 |
|
|
2021
Q2 | $372K | Sell |
780
-19
| -2% | -$8.02K | 0.19% | 137 |
|
|
2021
Q1 | $329K | Buy |
799
+11
| +1% | +$5.07K | 0.17% | 140 |
|
|
2020
Q4 | $386K | Sell |
788
-26
| -3% | -$15.2K | 0.23% | 124 |
|
|
2020
Q3 | $461K | Sell |
814
-1
| -0.1% | -$333 | 0.33% | 107 |
|
|
2020
Q2 | $78K | Sell |
815
-5
| -0.6% | -$439 | 0.06% | 150 |
|
|
2020
Q1 | $59K | Buy |
820
+44
| +6% | +$2.95K | 0.06% | 152 |
|
|
2019
Q4 | $54K | Sell |
776
-153
| -16% | -$11.3K | 0.04% | 153 |
|
|
2019
Q3 | $74K | Sell |
929
-4
| -0.4% | -$264 | 0.06% | 148 |
|
|
2019
Q2 | $60K | Hold |
933
| – | – | 0.05% | 147 |
|
|
2019
Q1 | $128K | Buy |
933
+100
| +12% | +$12.2K | 0.1% | 147 |
|
|
2018
Q4 | $75K | Sell |
833
-139
| -14% | -$19.5K | 0.07% | 149 |
|
|
2018
Q3 | $148K | Hold |
972
| – | – | 0.1% | 156 |
|
|
2018
Q2 | $167K | Sell |
972
-4
| -0.4% | -$653 | 0.12% | 152 |
|
|
2018
Q1 | $143K | Buy |
976
+21
| +2% | +$4.03K | 0.1% | 156 |
|
|
2017
Q4 | $194K | Buy |
955
+266
| +39% | +$54.7K | 0.14% | 154 |
|
|
2017
Q3 | $221K | Buy |
+689
| New | +$188K | 0.16% | 149 |
|
Other funds holding MCRB
FP
XT
Ironwood Investment Management's MCRB Position: Q2 2025 in Review
Ironwood Investment Management sold out of Seres Therapeutics (MCRB) in Q2 2025, closing a stake of 1,825 shares — an estimated $25.5K sold.
Ironwood Investment Management first reported a position in MCRB in Q3 2017 and held it in 31 quarters. The position peaked at $461K in Q3 2020. 33 funds tracked by Wall St. Rank hold MCRB as of Q2 2025.
- Ironwood Investment Management reported no remaining Seres Therapeutics position as of Q2 2025 after selling out during the quarter.
- Ironwood Investment Management sold 1,825 Seres Therapeutics shares in Q2 2025, an estimated $25.5K.
- Ironwood Investment Management first reported a position in Seres Therapeutics in Q3 2017 and held it in 31 quarters.
- Ironwood Investment Management's Seres Therapeutics position peaked at $461K in Q3 2020.
- 33 funds tracked by Wall St. Rank held Seres Therapeutics as of Q2 2025.
Based on Ironwood Investment Management's 13F filing for Q2 2025, filed 13 Aug 2025.